><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>J. L.</given-names></name><name><surname>Chan</surname><given-names>J.</given-names></name></person-group><article-title>Immunology of tuberculosis</article-title><source><italic>Annual Review of Immunology</italic></source><year>2001</year><volume>19</volume><fpage>93</fpage><lpage>129</lpage><pub-id pub-id-type="other">2-s2.0-0035064072</pub-id><pub-id pub-id-type="doi">10.1146/annurev.immunol.19.1.93</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>A. M.</given-names></name></person-group><article-title>Cell-mediated immune responses in tuberculosis</article-title><source><italic>Annual Review of Immunology</italic></source><year>2009</year><volume>27</volume><fpage>393</fpage><lpage>422</lpage><pub-id pub-id-type="other">2-s2.0-67650932256</pub-id><pub-id pub-id-type="doi">10.1146/annurev.immunol.021908.132703</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Garra</surname><given-names>A.</given-names></name><name><surname>Redford</surname><given-names>P. S.</given-names></name><name><surname>McNab</surname><given-names>F. W.</given-names></name><name><surname>Bloom</surname><given-names>C. I.</given-names></name><name><surname>Wilkinson</surname><given-names>R. J.</given-names></name><name><surname>Berry</surname><given-names>M. P. R.</given-names></name></person-group><article-title>The immune response in tuberculosis</article-title><source><italic>Annual Review of Immunology</italic></source><year>2013</year><volume>31</volume><fpage>475</fpage><lpage>527</lpage><pub-id pub-id-type="other">2-s2.0-84875498895</pub-id><pub-id pub-id-type="doi">10.1146/annurev-immunol-032712-095939</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>C. G.</given-names></name><name><surname>Jankovic</surname><given-names>D.</given-names></name><name><surname>Kullberg</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production</article-title><source><italic>Journal of Immunology</italic></source><year>2005</year><volume>174</volume><issue>7</issue><fpage>4185</fpage><lpage>4192</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.174.7.4185</pub-id><pub-id pub-id-type="other">2-s2.0-15444375415</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roediger</surname><given-names>E. K.</given-names></name><name><surname>Kugathasan</surname><given-names>K.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Lichty</surname><given-names>B. D.</given-names></name><name><surname>Xing</surname><given-names>Z.</given-names></name></person-group><article-title>Heterologous boosting of recombinant adenoviral prime immunization with a novel vesicular stomatitis virus-vectored tuberculosis vaccine</article-title><source><italic>Molecular Therapy</italic></source><year>2008</year><volume>16</volume><issue>6</issue><fpage>1161</fpage><lpage>1169</lpage><pub-id pub-id-type="other">2-s2.0-44349133474</pub-id><pub-id pub-id-type="doi">10.1038/mt.2008.59</pub-id><pub-id pub-id-type="pmid">18388911</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nolz</surname><given-names>J. C.</given-names></name><name><surname>Harty</surname><given-names>J. T.</given-names></name></person-group><article-title>Strategies and implications for prime-boost vaccination to generate memory CD8 T cells</article-title><source><italic>Advances in Experimental Medicine and Biology</italic></source><year>2011</year><volume>780</volume><fpage>69</fpage><lpage>83</lpage><pub-id pub-id-type="other">2-s2.0-80053592167</pub-id><pub-id pub-id-type="doi">10.1007/978-1-4419-5632-3_7</pub-id><pub-id pub-id-type="pmid">21842366</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>A. M.</given-names></name><name><surname>Solache</surname><given-names>A.</given-names></name><name><surname>Khader</surname><given-names>S. A.</given-names></name></person-group><article-title>Interleukin-12 and tuberculosis: an old story revisited</article-title><source><italic>Current Opinion in Immunology</italic></source><year>2007</year><volume>19</volume><issue>4</issue><fpage>441</fpage><lpage>447</lpage><pub-id pub-id-type="other">2-s2.0-34548008127</pub-id><pub-id pub-id-type="doi">10.1016/j.coi.2007.07.004</pub-id><pub-id pub-id-type="pmid">17702558</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Shea</surname><given-names>J. J.</given-names></name><name><surname>Visconti</surname><given-names>R.</given-names></name></person-group><article-title>Type I IFNs and regulation of TH I responses: Enigmas both resolved and emerge</article-title><source><italic>Nature Immunology</italic></source><year>2000</year><volume>1</volume><issue>1</issue><fpage>17</fpage><lpage>19</lpage><pub-id pub-id-type="other">2-s2.0-0034232036</pub-id><pub-id pub-id-type="doi">10.1038/76872</pub-id><pub-id pub-id-type="pmid">10881168</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x000e1;lez-Navajas</surname><given-names>J. M.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>David</surname><given-names>M.</given-names></name><name><surname>Raz</surname><given-names>E.</given-names></name></person-group><article-title>Immunomodulatory functions of type i interferons</article-title><source><italic>Nature Reviews Immunology</italic></source><year>2012</year><volume>12</volume><issue>2</issue><fpage>125</fpage><lpage>135</lpage><pub-id pub-id-type="other">2-s2.0-84856226112</pub-id><pub-id pub-id-type="doi">10.1038/nri3133</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrantini</surname><given-names>M.</given-names></name><name><surname>Capone</surname><given-names>I.</given-names></name><name><surname>Belardelli</surname><given-names>F.</given-names></name></person-group><article-title>Interferon-<italic>&#x003b1;</italic> and cancer: Mechanisms of action and new perspectives of clinical use</article-title><source><italic>Biochimie</italic></source><year>2007</year><volume>89</volume><issue>6-7</issue><fpage>884</fpage><lpage>893</lpage><pub-id pub-id-type="other">2-s2.0-34347272251</pub-id><pub-id pub-id-type="doi">10.1016/j.biochi.2007.04.006</pub-id><pub-id pub-id-type="pmid">17532550</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decker</surname><given-names>T.</given-names></name><name><surname>Stockinger</surname><given-names>S.</given-names></name><name><surname>Karaghiosoff</surname><given-names>M.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>M.</given-names></name><name><surname>Kovarik</surname><given-names>P.</given-names></name></person-group><article-title>IFNs and STATs in innate immunity to microorganisms</article-title><source><italic>Journal of Clinical Investigation</italic></source><year>2002</year><volume>109</volume><issue>10</issue><fpage>1271</fpage><lpage>1277</lpage><pub-id pub-id-type="other">2-s2.0-0036108577</pub-id><pub-id pub-id-type="doi">10.1172/JCI200215770</pub-id><pub-id pub-id-type="pmid">12021240</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNab</surname><given-names>F.</given-names></name><name><surname>Mayer-Barber</surname><given-names>K.</given-names></name><name><surname>Sher</surname><given-names>A.</given-names></name><name><surname>Wack</surname><given-names>A.</given-names></name><name><surname>O'Garra</surname><given-names>A.</given-names></name></person-group><article-title>Type I interferons in infectious disease</article-title><source><italic>Nature Reviews Immunology</italic></source><year>2015</year><volume>15</volume><issue>2</issue><fpage>87</fpage><lpage>103</lpage><pub-id pub-id-type="other">2-s2.0-84923000335</pub-id><pub-id pub-id-type="doi">10.1038/nri3787</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>A. M.</given-names></name><name><surname>Mayer-Barber</surname><given-names>K. D.</given-names></name><name><surname>Sher</surname><given-names>A.</given-names></name></person-group><article-title>Role of innate cytokines in mycobacterial infection</article-title><source><italic>Mucosal Immunology</italic></source><year>2011</year><volume>4</volume><issue>3</issue><fpage>252</fpage><lpage>260</lpage><pub-id pub-id-type="other">2-s2.0-79955110091</pub-id><pub-id pub-id-type="doi">10.1038/mi.2011.13</pub-id><pub-id pub-id-type="pmid">21430655</pub-id></element-citation></ref><ref id="B17"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bracci</surname><given-names>L.</given-names></name><name><surname>Canini</surname><given-names>I.</given-names></name><name><surname>Puzelli</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level</article-title><source><italic>Vaccine</italic></source><year>2005</year><volume>23</volume><issue>23</issue><fpage>2994</fpage><lpage>3004</lpage><pub-id pub-id-type="other">2-s2.0-16244389282</pub-id><pub-id pub-id-type="doi">10.1016/j.vaccine.2004.12.006</pub-id><pub-id pub-id-type="pmid">15811645</pub-id></element-citation></ref><ref id="B18"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Couch</surname><given-names>R. B.</given-names></name><name><surname>Atmar</surname><given-names>R. L.</given-names></name><name><surname>Cate</surname><given-names>T. R.</given-names></name><etal/></person-group><article-title>Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans</article-title><source><italic>Vaccine</italic></source><year>2009</year><volume>27</volume><issue>39</issue><fpage>5344</fpage><lpage>5348</lpage><pub-id pub-id-type="other">2-s2.0-68449089230</pub-id><pub-id pub-id-type="doi">10.1016/j.vaccine.2009.06.084</pub-id><pub-id pub-id-type="pmid">19607949</pub-id></element-citation></ref><ref id="B15"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teles</surname><given-names>R. M. B.</given-names></name><name><surname>Graeber</surname><given-names>T. G.</given-names></name><name><surname>Krutzik</surname><given-names>S. R.</given-names></name><etal/></person-group><article-title>Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses</article-title><source><italic>Science</italic></source><year>2013</year><volume>339</volume><issue>6126</issue><fpage>1448</fpage><lpage>1453</lpage><pub-id pub-id-type="other">2-s2.0-84875425732</pub-id><pub-id pub-id-type="doi">10.1126/science.1233665</pub-id><pub-id pub-id-type="pmid">23449998</pub-id></element-citation></ref><ref id="B19"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manca</surname><given-names>C.</given-names></name><name><surname>Tsenova</surname><given-names>L.</given-names></name><name><surname>Bergtold</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-<italic>&#x003b1;</italic>/<italic>&#x003b2;</italic></article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2001</year><volume>98</volume><issue>10</issue><fpage>5752</fpage><lpage>5757</lpage><pub-id pub-id-type="other">2-s2.0-0035826721</pub-id><pub-id pub-id-type="doi">10.1073/pnas.091096998</pub-id><pub-id pub-id-type="pmid">11320211</pub-id></element-citation></ref><ref id="B20"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Telesca</surname><given-names>C.</given-names></name><name><surname>Angelico</surname><given-names>M.</given-names></name><name><surname>Piccolo</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Interferon-alpha treatment of hepatitis D induces tuberculosis exacerbation in an immigrant</article-title><source><italic>Journal of Infection</italic></source><year>2007</year><volume>54</volume><issue>4</issue><fpage>e223</fpage><lpage>e226</lpage><pub-id pub-id-type="other">2-s2.0-33947206161</pub-id><pub-id pub-id-type="doi">10.1016/j.jinf.2006.12.009</pub-id><pub-id pub-id-type="pmid">17307255</pub-id></element-citation></ref><ref id="B21"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>M. P. R.</given-names></name><name><surname>Graham</surname><given-names>C. M.</given-names></name><name><surname>McNab</surname><given-names>F. W.</given-names></name><etal/></person-group><article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title><source><italic>Nature</italic></source><year>2010</year><volume>466</volume><issue>7309</issue><fpage>973</fpage><lpage>977</lpage><pub-id pub-id-type="other">2-s2.0-77955894773</pub-id><pub-id pub-id-type="doi">10.1038/nature09247</pub-id><pub-id pub-id-type="pmid">20725040</pub-id></element-citation></ref><ref id="B22"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>K. D.</given-names></name><name><surname>Andrade</surname><given-names>B. B.</given-names></name><name><surname>Oland</surname><given-names>S. D.</given-names></name><etal/></person-group><article-title>Host-directed therapy of tuberculosis based on interleukin-1 and type i interferon crosstalk</article-title><source><italic>Nature</italic></source><year>2014</year><volume>511</volume><issue>7507</issue><fpage>99</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1038/nature13489</pub-id><pub-id pub-id-type="other">2-s2.0-84903750131</pub-id><pub-id pub-id-type="pmid">24990750</pub-id></element-citation></ref><ref id="B23"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerrero</surname><given-names>G. G.</given-names></name><name><surname>Rangel-Moreno</surname><given-names>J.</given-names></name><name><surname>Islas-Trujillo</surname><given-names>S.</given-names></name><name><surname>Rojas-Espinosa</surname><given-names>O.</given-names></name></person-group><article-title>Successive intramuscular boosting with IFN-alpha protects mycobacterium bovis BCG-vaccinated mice against M. lepraemurium infection</article-title><source><italic>BioMed Research International</italic></source><year>2015</year><volume>2015</volume><fpage>9</fpage><pub-id pub-id-type="publisher-id">414027</pub-id><pub-id pub-id-type="doi">10.1155/2015/414027</pub-id><pub-id pub-id-type="other">2-s2.0-84943339857</pub-id></element-citation></ref><ref id="B25"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>L. C.</given-names></name><name><surname>Diwan</surname><given-names>V. K.</given-names></name><name><surname>Wheeler</surname><given-names>J. G.</given-names></name></person-group><article-title>Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis</article-title><source><italic>International Journal of Epidemiology</italic></source><year>1993</year><volume>22</volume><issue>6</issue><fpage>1154</fpage><lpage>1158</lpage><pub-id pub-id-type="doi">10.1093/ije/22.6.1154</pub-id><pub-id pub-id-type="other">2-s2.0-0027751819</pub-id><pub-id pub-id-type="pmid">8144299</pub-id></element-citation></ref><ref id="B26"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skeiky</surname><given-names>Y. A. W.</given-names></name><name><surname>Sadoff</surname><given-names>J. C.</given-names></name></person-group><article-title>Advances in tuberculosis vaccine strategies</article-title><source><italic>Nature Reviews Microbiology</italic></source><year>2006</year><volume>4</volume><issue>6</issue><fpage>469</fpage><lpage>476</lpage><pub-id pub-id-type="other">2-s2.0-33646822975</pub-id><pub-id pub-id-type="doi">10.1038/nrmicro1419</pub-id><pub-id pub-id-type="pmid">16710326</pub-id></element-citation></ref><ref id="B27"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>P.</given-names></name><name><surname>Doherty</surname><given-names>T. M.</given-names></name></person-group><article-title>The success and failure of BCG&#x02014;implications for a novel tuberculosis vaccine</article-title><source><italic>Nature Reviews Microbiology</italic></source><year>2005</year><volume>3</volume><issue>8</issue><fpage>656</fpage><lpage>662</lpage><pub-id pub-id-type="doi">10.1038/nrmicro1211</pub-id><pub-id pub-id-type="other">2-s2.0-22944433876</pub-id><pub-id pub-id-type="pmid">16012514</pub-id></element-citation></ref><ref id="B28"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menozzi</surname><given-names>F. D.</given-names></name><name><surname>Bischoff</surname><given-names>R.</given-names></name><name><surname>Fort</surname><given-names>E.</given-names></name><name><surname>Brennan</surname><given-names>M. J.</given-names></name><name><surname>Locht</surname><given-names>C.</given-names></name></person-group><article-title>Molecular characterization of the mycobacterial heparin-binding hemagglutinin, a mycobacterial adhesin</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>1998</year><volume>95</volume><issue>21</issue><fpage>12625</fpage><lpage>12630</lpage><pub-id pub-id-type="other">2-s2.0-0032514676</pub-id><pub-id pub-id-type="doi">10.1073/pnas.95.21.12625</pub-id><pub-id pub-id-type="pmid">9770536</pub-id></element-citation></ref><ref id="B29"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerrero</surname><given-names>G. G.</given-names></name><name><surname>Debrie</surname><given-names>A.-S.</given-names></name><name><surname>Locht</surname><given-names>C.</given-names></name></person-group><article-title>Boosting with mycobacterial heparin-binding haemagglutinin enhances protection of Mycobacterium bovis BCG-vaccinated newborn mice against M. tuberculosis</article-title><source><italic>Vaccine</italic></source><year>2010</year><volume>28</volume><issue>27</issue><fpage>4340</fpage><lpage>4347</lpage><pub-id pub-id-type="other">2-s2.0-77952744996</pub-id><pub-id pub-id-type="doi">10.1016/j.vaccine.2010.04.062</pub-id><pub-id pub-id-type="pmid">20447476</pub-id></element-citation></ref><ref id="B24"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giacomini</surname><given-names>E.</given-names></name><name><surname>Remoli</surname><given-names>M. E.</given-names></name><name><surname>Gafa</surname><given-names>V.</given-names></name><name><surname>Pardini</surname><given-names>M.</given-names></name><name><surname>Fattorini</surname><given-names>L.</given-names></name><name><surname>Coccia</surname><given-names>E. M.</given-names></name></person-group><article-title>IFN-<italic>&#x003b2;</italic> improves BCG immunogenicity by acting on DC maturation</article-title><source><italic>Journal of Leukocyte Biology</italic></source><year>2009</year><volume>85</volume><issue>3</issue><fpage>462</fpage><lpage>468</lpage><pub-id pub-id-type="other">2-s2.0-61449109077</pub-id><pub-id pub-id-type="doi">10.1189/jlb.0908583</pub-id><pub-id pub-id-type="pmid">19056860</pub-id></element-citation></ref><ref id="B30"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maher</surname><given-names>D.</given-names></name><name><surname>Raviglione</surname><given-names>M.</given-names></name></person-group><article-title>Global epidemiology of tuberculosis</article-title><source><italic>Clinics in Chest Medicine</italic></source><year>2005</year><volume>26</volume><issue>2</issue><fpage>167</fpage><lpage>182</lpage><pub-id pub-id-type="other">2-s2.0-17044394716</pub-id><pub-id pub-id-type="doi">10.1016/j.ccm.2005.02.009</pub-id><pub-id pub-id-type="pmid">15837103</pub-id></element-citation></ref><ref id="B31"><label>29</label><element-citation publication-type="other"><collab>WHO</collab><article-title>World Health Organization: Tuberculosis&#x02014;Global Facts 2011/2102</article-title><comment>Geneva: WHO Stop TB Department, 2012, <ext-link ext-link-type="uri" xlink:href="http://www.who.int/tb/publications/2011/factsheet_tb_2011.pdf">http://www.who.int/tb/publications/2011/factsheet_tb_2011.pdf</ext-link></comment></element-citation></ref></